Expertise in
12
conditions

Julian D. Gillmore

Rowland Hill Street, 
London, ENG, GB 
Expertise in
12
conditions
Rowland Hill Street, 
London, ENG, GB 

Overview

Julian Gillmore practices practicing medicine in London, United Kingdom.

Mr. Gillmore is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Primary Amyloidosis, Cardiac Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Bone Marrow Aspiration, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 382 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Rowland Hill Street, London, ENG, United Kingdom
Other Locations
UCL Queen Square Institute Of Neurology, London, ENG, United Kingdom
St George's University Of London, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised Double-blind, Placebo-controlled Phase I/IIa Trial to Investigate the Effect of Depletion of Serum Amyloid P Component (SAP) on the Immune Response to DNA Vaccination in Healthy Male Volunteers
A Randomised Double-blind, Placebo-controlled Phase I/IIa Trial to Investigate the Effect of Depletion of Serum Amyloid P Component (SAP) on the Immune Response to DNA Vaccination in Healthy Male Volunteers
Enrollment Status: Completed
Publish Date: March 26, 2020
Intervention Type: Biological, Drug, Other
Study Phase: Phase 1/Phase 2

382 Total Publications

Natriuretic Peptide and Transthyretin and Their Relationship With Clinical Outcomes: Results From ATTRIBUTE-CM, a Randomized Controlled Trial.
Natriuretic Peptide and Transthyretin and Their Relationship With Clinical Outcomes: Results From ATTRIBUTE-CM, a Randomized Controlled Trial.
Journal: Journal of the American Heart Association
Published: August 31, 2026

Frequently Asked Questions about Julian D. Gillmore

Is Julian D. Gillmore a top-rated expert for Primary Amyloidosis?

MediFind is an objective health platform that identifies experts based on real-world data. Julian D. Gillmore is classified as an Elite expert for Primary Amyloidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Julian D. Gillmore participate in research or clinical trials?

Yes. Julian D. Gillmore has published 382 articles and abstracts on conditions like Primary Amyloidosis. You can view a list of Julian D. Gillmore's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gillmore's expertise for a condition
ConditionClose
View All 38 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile